Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
2017_-_fall-term [2017/09/13 10:20] mohamesb |
2017_-_fall-term [2018/01/25 15:18] (current) |
||
|---|---|---|---|
| Line 3: | Line 3: | ||
| [[ Group 1, Presentation 1 - Breast Cancer]] | [[ Group 1, Presentation 1 - Breast Cancer]] | ||
| - | [[ Group 2, Presentation 1 - ]] | + | [[ Group 2, Presentation 1 - Glioblastoma]] |
| === === | === === | ||
| [[ Group 3, Presentation 1 - AL Amyloidosis]] | [[ Group 3, Presentation 1 - AL Amyloidosis]] | ||
| Line 9: | Line 9: | ||
| [[ Group 4, Presentation 1 - Post-Traumatic Stress Disorder]] | [[ Group 4, Presentation 1 - Post-Traumatic Stress Disorder]] | ||
| === === | === === | ||
| - | [[ Group 5, Presentation 1 - Cushing's]] | + | [[ Group 5, Presentation 1 - Glucocorticoid Hyperfunction (Cushing's Syndrome)]] |
| === === | === === | ||
| === === | === === | ||
| Line 15: | Line 15: | ||
| [[ Group 1, Presentation 2 -Alzheimer's Disease]] | [[ Group 1, Presentation 2 -Alzheimer's Disease]] | ||
| === === | === === | ||
| - | [[ Group 2, Presentation 2 - ]] | + | [[ Group 2, Presentation 2 - Epilepsy]] |
| === === | === === | ||
| - | [[ Group 3, Presentation 2 - LSD's (lysergic acid diethylamide) effect on the brain]] | + | [[ Group 3, Presentation 2 - Lysergic Acid Diethylamide (LSD)]] |
| === === | === === | ||
| [[ Group 4, Presentation 2 -Aplastic Anemia ]] | [[ Group 4, Presentation 2 -Aplastic Anemia ]] | ||
| === === | === === | ||
| - | [[ Group 5, Presentation 2 - Hyperbilirubinemia: Jaundice]] | + | [[ Group 5, Presentation 2 - Hyperbilirubinemia (Jaundice)]] |
| === === | === === | ||
| === === | === === | ||
| Line 27: | Line 27: | ||
| [[ Group 1, Presentation 3 - Parkinson's Disease ]] | [[ Group 1, Presentation 3 - Parkinson's Disease ]] | ||
| === === | === === | ||
| - | [[ Group 2, Presentation 3 - ]] | + | [[ Group 2, Presentation 3 - Ebola ]] |
| === === | === === | ||
| - | [[ Group 3, Presentation 3 - Venom from a Brazilian Wandering Spider and its effect on our body]] | + | [[ Group 3, Presentation 3 - Snake Venom]] |
| === === | === === | ||
| [[ Group 4, Presentation 3 -Burns ]] | [[ Group 4, Presentation 3 -Burns ]] | ||
| Line 35: | Line 35: | ||
| [[ Group 5, Presentation 3 - Chronic Myeloid Leukemia]] | [[ Group 5, Presentation 3 - Chronic Myeloid Leukemia]] | ||
| === === | === === | ||
| - | {{::screen_shot_2017-09-05_at_1.47.03_pm.png?200|}} | + | {{::4M03_2017_Fall Term_List.png?200|}} |
